Another Way to Calculate Risk in Cystic Fibrosis Lung Transplantation Patients
Researchers have developed a new tool to calculate the risk of poor outcomes both post-transplant and during the waiting period.
Researchers have developed a new tool to calculate the risk of poor outcomes both post-transplant and during the waiting period.
A woman in Michigan contracted COVID-19 and died after receiving an infected double-lung transplant from a donor, according to multiple news reports.
MedUni Vienna/Vienna General Hospital carried out a lung transplant on a 45-year-old woman who developed severe respiratory failure as a result of COVID-19.
Some physicians have begun prescribing everolimus to treat Lymphangioleiomyomatosis (LAM), which may not have the same risks as other rapamycin-class drugs.
Read More